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Abstract
Acute Kidney Injury (AKI) is a common clinical syndrome characterized
by the rapid loss of kidney excretory function, which aggravates the clin-
ical severity of other diseases in a large number of hospitalized patients.
Accurate early prediction of AKI can enable in-time interventions and treat-
ments. However, AKI is highly heterogeneous, thus identification of AKI
sub-phenotypes can lead to an improved understanding of the disease patho-
physiology and development of more targeted clinical interventions. This
study used a memory network-based deep learning approach to discover AKI
sub-phenotypes using structured and unstructured electronic health record
(EHR) data of patients before AKI diagnosis. We leveraged a real world
critical care EHR corpus including 37,486 ICU stays. Our approach identi-
fied three distinct sub-phenotypes: sub-phenotype I is with an average age
of 63.03±17.25 years, and is characterized by mild loss of kidney excretory
function (Serum Creatinine (SCr) 1.55± 0.34 mg/dL, estimated Glomerular
Filtration Rate Test (eGFR) 107.65±54.98 mL/min/1.73m2). These patients
are more likely to develop stage I AKI. Sub-phenotype II is with average age
66.81±10.43 years, and was characterized by severe loss of kidney excretory
function (SCr 1.96 ± 0.49 mg/dL, eGFR 82.19 ± 55.92 mL/min/1.73m2).
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These patients are more likely to develop stage III AKI. Sub-phenotype III
is with average age 65.07±11.32 years, and was characterized moderate loss
of kidney excretory function and thus more likely to develop stage II AKI
(SCr 1.69 ± 0.32 mg/dL, eGFR 93.97 ± 56.53 mL/min/1.73m2). Both SCr
and eGFR are significantly different across the three sub-phenotypes with
statistical testing plus postdoc analysis, and the conclusion still holds after
age adjustment.
1. Introduction
Acute Kidney Injury (AKI) is a critical clinical event characterized by a
sudden decrease in kidney function, which affects about 15% of all hospital-
izations and more than 50% of patients in intensive care unit (ICU) (Cheng
et al., 2017). It is a complex condition, which rarely possesses an unique and
obvious pathophysiology (Makris and Spanou, 2016). Patients with AKI
usually present a complex etiology, which involves different causes and com-
plicates the clinical manifestations and treatments (Tomasˇev et al., 2019).
For example, sepsis, ischemia, and the nephrotoxicity of drugs frequently co-
occur in patients with AKI (Makris and Spanou, 2016; Chertow et al., 2005).
Moreover, AKI is a progressive kidney function disorder and has multiple
stages in terms of severity, which is associated with a broad spectrum of clin-
ical factors including creatinine, chloride, and hemoglobin measurements, as
well as heart and respiration rates. Therefore, identification of AKI subtypes
can lead to an improved understanding of the underlying disease etiology
and the future development of more targeted interventions and therapies.
However, due to the complexity and heterogeneity of AKI, it is challenging
to define AKI sub-phenotypes accurately based on clinical knowledge.
In recent years, due to wider availability of electronic health record (EHR)
data, researchers have developed data-driven approaches to identify disease
sub-phenotypes using EHR data (Fereshtehnejad et al., 2017; Maglanoc et al.,
2019). From a data-driven perspective, patient sub-phenotyping is essentially
a clustering problem (Zhang et al., 2019; Fereshtehnejad et al., 2017), where
patients in the same ”sub-phenotype cluster” tend to be more similar to each
other based on disease manifestations derived from their EHRs. Generally
speaking, there are three steps for the task of data-driven discovery of sub-
phenotypes using EHRs:
• Representation. For each patient in the dataset, we need to first con-
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struct an appropriate representation (e.g., vectors (Sun et al., 2012),
matrices (Wang et al., 2013), tensors (Luo et al., 2016a) or sequences
(Baytas et al., 2017)) of their information derived from the EHRs.
• Clustering. Next, we need to develop or adopt existing clustering al-
gorithms (e.g., hierarchical agglomerative clustering (Fereshtehnejad
et al., 2017) or K-means (Zhang et al., 2019)) based on the patient rep-
resentations derived from previous step to acquire the patient clusters.
Each cluster corresponds to an unique sub-phenotype.
• Interpretation. After the patient clusters are obtained, we need to
derive a clinical characterization for each of them (usually by identifi-
cation of features that are discriminative across the different clusters
through statistical testing (Fereshtehnejad et al., 2017; Zhang et al.,
2019)). This step allows us to appropriately interpret the computa-
tionally derived clusters.
Several prior studies have demonstrated the utility of data-driven sub-
phenotyping with patient EHRs. For example, Ho et al. (Ho et al., 2014)
developed a tensor factorization based phenotyping approach that was capa-
ble of exploring the interactions among different modalities in the EHR data
(e.g., diagnosis and medication). Zhou et al. (Zhou et al., 2014) proposed a
matrix factorization algorithm to first reduce the dimensionality of the event
space in the EHRs and then derive the the patient phenotypes in the low-
dimensional space. Baytas et al. (Baytas et al., 2017) further developed a
deep learning approach to exploit the event temporalities in patient EHR.
While promising, these prior efforts were limited to analyzing only structured
EHR data. More recent work has also investigated unstructured EHR data
to computationally derive sub-phenotypes (Halpern et al., 2016; McCoy Jr
et al., 2018). In reality, both structured and unstructured EHR data contain
important information about the patients, and therefore, an ideal solution to
derive sub-phenotype should integrate all available EHR data. To this end,
Pivovarov et al. (Pivovarov et al., 2015) proposed a mixture topic modeling
approach for large-scale discovery of computational models of disease or phe-
notypes. However, their method does not explore the temporality between
the clinical events documented in both structured and unstructured EHR
data.
In this study, we propose a deep learning model architecture to iden-
tify sub-phenotypes of AKI using longitudinal structured and unstructured
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EHR data. In particular, this study contains two goals. The first goal is to
obtain effective representations that can accurately predict the incidence of
AKI cases, and the second goal is to identify AKI subtypes on the obtained
representations. More concretely, our approach is composed of three steps:
• In the representation step, we choose memory network (MN)
(Sukhbaatar et al., 2015) as the backbone of our model, wherein the
structured event sequences are inserted into the memory network and
the unstructured clinical note series are transformed into a vector
through a hierarchical Long Short Term Memory (HieLSTM) model.
The vector is then combined with useful information extracted from the
memory network to construct a vector representation for each patient.
We optimize the model parameters such that the final representation
vector can lead to the best prediction performance of a future AKI risk.
• In the clustering step, we first used the student t-distributed Stochas-
tic Neighbor Embedding (t-SNE)(Maaten and Hinton, 2008; Van
Der Maaten et al., 2009) to project the patient vectors obtained into a
two-dimensional space such that the cluster structure can be inspected
visually, and then performed K-means clustering to obtain the patient
clusters.
• In the interpretation step, we performed statistical testing and man-
ual evaluation to identify the features that are discriminant across the
clusters, and used those features for defining disease sub-phenotypes.
We applied this approach to detect AKI sub-phenotypes using the EHRs
from the MIMIC III data set (Johnson et al., 2016), where three distinct
sub-phenotypes were identified that align with the different stages of AKI.
In the following we introduce our study in detail.
2. Methods
2.1. Data Set, AKI Case Definition, and Patient Features
The EHR data used in this study is from the Medical Information Mart
for Intensive Care III (MIMIC-III) database (Johnson et al., 2016), which
is a de-identified and publicly available data set. It contains approximately
sixty thousand admissions of patients who stayed in critical care units of the
Beth Israel Deaconess Medical Center between 2001 and 2012. The patient
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information contained in this database includes patient demographics, vital
signs, laboratory test results, procedures, medications, clinical notes, imaging
reports, and patient mortality.
AKI Case Definition: There are four commonly used AKI diagnostic cri-
teria: the Risk-Injury-Failure-Loss-End (RIFLE) criteria (Bellomo et al.,
2004), then pediatric RIFLE (pRIFLE) criteria (Akcan-Arikan et al., 2007),
the Acute Kidney Injury Network (AKIN) criteria (Pickering and Endre,
2009), and the Kidney Disease: Improving Global Outcomes (KDIGO) cri-
teria (Kellum et al., 2012). KDIGO is the latest and it unified the previous
criteria in 2012, which improves the sensitivity of AKI diagnosis and has
been widely used by researchers (Makris and Spanou, 2016; Li et al., 2018).
In this study, we employ the KDIGO criteria to define AKI cases as follows:
(1) Increase in Serum Creatinine (Scr) by ≥ 0.3 mg/dl (≥26.5 mol/l) within
48h; or (2) Increase in SCr to ≥1.5 times from the baseline, which is known
or presumed to have occurred within the prior 7 days; or (3) Urine volume
< 0.5 ml/kg/h for 6h. Moreover, as we will interpret the data-driven sub-
phenotypes based on AKI stages, we will consider the following criteria from
KDIGO for AKI staging:
Stage 1: SCr is 1.5-1.9 times of baseline, which is known or presumed
to have occurred within the prior 7 days; or no less than 0.3 mg/dL (26.5
mol/L) absolute increase in SCr within 48h; or urine volume is less than 0.5
mL/kg/h for 6-12 hours.
Stage 2: SCr is no less than 2.0-2.9 times of baseline, which is known or
presumed to have occurred within the prior 7 days; or urine volume is less
than 0.5 mL/kg/h for no less than 12 hours.
Stage 3: SCr is no less than 3.0 times from baseline, which is known
or presumed to have occurred within the prior 7 days; or increase in SCr
is no less than 4.0 mg/dL (353.6 mol/L) within 48h; or initiation of renal
replacement therapy; or urine volume is less than 0.3 mL/kg/h for no less
than 24 hours; or anuria for no less than 12 hours; or renal replacement
therapy required.
Patient Features : We extracted several groups of features from MIMIC-
III as follows1.
• Demographics: Gender, age and ethnicity.
1Additional details about features can referred (Luo et al., 2016b) and be found at
https://github.com/xuzhenxing2018/amia/blob/master/features_name.xlsx
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• Medications: Medications that were administered from the patients’
ICU admission until prediction time. Based on literature analysis and
the KDIGO criteria, we mainly consider the following categories: di-
uretics, Non-steroidal anti-inflammatory drugs (NSAID), radiocontrast
agents, and angiotensin.
• Comorbidities: Comorbidities that the patients already have. Based
on literature analysis and the KDIGO criteria, we mainly consider the
following categories: congestive heart failure, peripheral vascular, hy-
pertension, diabetes, liver disease, myocardial infarction (MI), coronary
artery disease (CAD), cirrhosis, and jaundice.
• Chart-events: Vital signs measured at the bedside. Based on liter-
ature analysis and the KDIGO criteria, we mainly consider diastolic
blood pressure (DiasBP), glucose, heart rate, mean arterial blood pres-
sure (MeanBP), respiration rate, blood oxygen saturation level (SpO2),
systolic blood pressure (SysBP), and temperature.
• Lab-events: Laboratory test results performed prior to and during the
ICU stay. Based on literature analysis and the KDIGO criteria, we
consider the following tests: bicarbonate, blood urea nitrogen (BUN),
calcium, chloride, creatinine, hemoglobin, international normalized ra-
tio (INR), platelet, potassium, prothrombin time (PT), partial throm-
boplastin time (PTT), white blood count (WBC), the average of urine
output, and the minimum value of estimated glomerular filtration rate
(eGFR) that is computed by MDRD (Modification of Diet in Renal
Disease) 4-Variable Equation including age, sex, ethnicity, and serum
creatinine (Levey et al., 2006).
2.2. Experimental Setting and Data Pre-Processing
As discussed in the Introduction, the first step of data-driven sub-
phenotyping is to learn an appropriate representation for each patient. In our
approach, we expect such representation can effectively predict future AKI
risk. In particular, because MIMIC-III mainly contains ICU admission data
for the patients in critical care, and the same individual might have multiple
ICU stays, we define AKI cases and controls based on the records in each
ICU stay. More concretely, let t1 be the elapsed time (in hours) after the
patient was admitted to ICU, from which we will extract the patient records
to train our model. Thus t1 is also referred to as observation window. The
6
Figure 1: An illustration of AKI prediction in our experimental setting. PP: prediction
point; DCW: data collection window; PW: prediction window.
AKI case/control label is defined on the records within t2 after t1. Thus t2
is also referred to as prediction window. In this study, t1 is set to 24 hours
(or 48 hours) and t2 is set to 7 days. The illustration of experimental setting
is shown in Figure 1. We choose 7-days as the prediction window according
to the definition of AKI by KDIGO criteria. Related study would suggest
7 days as the cut-off for diagnosing AKI (Schneider and Ostermann, 2017).
While the 0.3 mg/dl increase for urine is within 48 hours, the definition of
stage 1, 2, 3 are 1.5 times of baseline, 2 times of baseline, 3 times of baseline
within 7 days, respectively. Technically, when a patient enters the ICU unit
they might not have had any kidney injury but the thought is that many
of them are at risk due to low blood pressure, inflammation, or sepsis. We
exclude patients who were admitted with AKI in the ICU and had AKI in
the first 24 hours (or 48 hours) in the ICU. We also exclude patients whose
SCr and urine data are missing from the prediction window.
For data pre-processing, we first categorize the observation window into a
set of equal-length sub-windows, and we set the sub-window length to 2 hours
in our study. The values for each variable are averaged over each sub-window.
We impute the missing values by the variable mean and further uniformly
scale the values for each variable into the region between 0 and 1. The
discrete variables (e.g., medication and comorbidities) are encoded as zero-
one multi-hot vectors. For unstructured data, each clinical note is modeled
as a sequence of words. The medical term dictionary was constructed based
on our prior work (Li et al., 2018), which was further leveraged to filter the
clinical notes. In this study, each piece of clinical notes is modeled as a
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sequence of words, which can keep important medical term words and some
corresponding context words. These context words can provide some useful
information for modelling each piece of clinical notes when using some deep
learning based methods. From these notes, we can obtain some evidence and
relationships in terms of the progress of different diseases. Note that, we do
not use all words in notes, because the researchers removed some words when
building medical term dictionary, e.g., the words with document-frequency
under 100 were removed to reduce noise. More details in terms of the process
of building medical term dictionary can be referred (Li et al., 2018). Note
that each ICU stay typically contains multiple clinical notes. Based on these
aforementioned data pre-processing steps, we end up with a total of 37,486
ICU stays including 7,657 AKI cases from 6,933 unique patients, and 29,829
controls from 24,366 unique patients.
2.3. The Proposed Model
As stated in the Introduction, there are three key steps in our model.
The first step is to construct effective representation vectors. The overall
architecture of our model is shown in Figure 2, where we use memory net-
works (MN) (Weston et al., 2014; Sukhbaatar et al., 2015) as the backbone.
The general assumption here is that the AKI risk during a specific ICU stay
will be dependent on the information contained in the series of clinical notes
(extracted from a hierarchical LSTM model) and structured fields (such as
lab tests, vital signs, etc., which are stored in the memory bank) in the EHR
before the prediction time point. We further elaborate our model in the
following.
MN models have been demonstrated to be very effective in Question-
Answering problems (Miller et al., 2016; Bordes et al., 2015). The general
setup of an MN model includes a set of inputs x that are to be stored in
the memory (which contain information of potential answers), a query q,
and an answer a. The MN model compares an input query q with the in-
formation in the memory x and retrieves useful information that is similar
to q, and then combines the query with the retrieved memory information
to predict what would be the right answer. Compared to conventional deep
learning models such as Recurrent Neural Network (RNN) (Mikolov et al.,
2010), MN models can explicitly control parts of information in the mem-
ory that will be extracted, which is much more flexible and interpretable.
Multiple previous studies demonstrated that MN based models can obtain
better performance than several deep learning models (e.g., LSTM) (Weston
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et al., 2014; Sukhbaatar et al., 2015). In addition, although several tradi-
tional deep learning models (e.g., LSTM) can integrate multi-model data
(Rajkomar et al., 2018), the design of query, answer, and memory in the
MN models has a potential to integrate multi-model data to obtain good
performance (Zhang et al., 2018).
In our setting, for each ICU stay, our goal is to learn patient represen-
tations that can best predict a future AKI risk. We propose to insert the
structured EHR information within the observation window into the mem-
ory, and transform the series of clinical notes into a query vector. We then
compare the query vector with the contents in the memory slots and extract
relevant information which are combined with the query to make the AKI
prediction. Two major operations in our model are reading and retrieving as
discussed below.
Clinical sequences reading: In the MN model, suppose there is an input
clinical sequence sj, j = 1, ..., t, where j and t are the index of time slots
and the number of time slots, respectively. Each item in sj is the value
of some clinical variables extracted from the EHR at a certain timestamp.
We mainly incorporate time-dependent structured information from charts
events variables (e.g., heart rate, respiration rate, systolic blood pressure, and
temperature) and lab test results (e.g., calcium, chloride, platelet, creatinine
and potassium) into the memory. We employ a fixed number of timestamps
t to define the memory size. An embedding matrix A is used to transform
input clinical sequences into continuous vectors zj = Asj, and stored into
the memory, which are regarded as a new input memory representation.
Meanwhile, we use another embedding matrix B to obtain output memory
vectors ej = Bsj.
Memory retrieving: The retrieving of memory representation is to find
memory vectors from the embedding space. Since different clinical variables
in a sequence can contribute differently when it comes to the representation
learning for clinical notes, it is necessary to decide which vector to choose.
Attentive weights are used here to make a soft combination of all memory
vectors. In particular, the weights α are computed by a softmax function
on the inner product of the input memory zi and the learned query vector u
from the clinical notes:
αi = Softmax(u
T zi) (1)
where Softmax(ri) = e
ri/
∑
j e
rj . Defined in this way α is a probability
vector over the inputs. Once these weights are obtained, we use these weights
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and output memory vectors ei to obtain a vector o as
o =
∑
i
αiei, (2)
which is combined with u to form a integrated vector v to represent the
integrated information within the observation window of an ICU stay.
Generally speaking, such a memory mechanism allows the network to read
the input sequences multiple times to update the memory contents at each
step and then make a final output. The architecture of multiple layers can be
used to collect the information from the memory iteratively and cumulatively
for learning the presentations of patients (Rush et al., 2015; Xu et al., 2015).
In particular, suppose there are L layer memories for L hop operations, the
output feature map at the l − th hop can be rewritten as
ul+1 = Hul + ol, (l = 1, ..., L) (3)
where H is a linear mapping and can be beneficial to the iterative updating of
u. In addition, a layer-wise updating strategy for input and output memory
vectors at multiple hops are used, which maintains the same embedding as
A1 = ... = AL and B1 = ... = BL. More details in terms of the process of
using multiple layers in memory networks can be referred (Sukhbaatar et al.,
2015).
To transform the clinical note series into a vector representation u, we use
a two-layer hierarchical LSTM (HieLSTM) model. In particular, each ICU
stay in the MIMIC dataset comprises multiple clinical notes with timestamps.
The bottom layer LSTM is built on each specific clinical note whose word
sequence is served as the input. The embedding vector in the hidden layer
of the last word is the output. By concatenating the output vectors for all
clinical notes in each ICU stay according to their timestamps we obtain the
input of the top layer LSTM, and the embedding vector in the hidden layer
at the last timestamp will be used as the query.
We compute the probability distribution over the binary class by
P = Softmax(wTv) (4)
where w is the coefficient vector and v is the vector combined with memory
output o and query u. During training, we use cross-entropy to compute the
prediction loss
L =
N∑
i
yilogpi + (1− yi)log(1− pi) (5)
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where yi denotes the label for the i-th ICU stay, and N is the total number
of ICU stays in training data set.
Our model is implemented with tensorflow 1.7.0 (Abadi et al., 2016) and
trained on workstations with NVIDIA TESTA V100 GPUs with mini-batch
Adam optimizer (Kingma and Ba, 2014; Zhang et al., 2018).
Based on prior research (Sukhbaatar et al., 2015), we set the memory size
and the dimension of embedding as 12 and 128, respectively. For HieLSTM,
the dimension of each hidden units in the bottom and top LSTMs are set as
200 and 128, respectively. The final dimension of representation of each ICU
stay is 144. In addition, batch size, learning rate, and epoch number are set
as 32, 0.01, and 10, respectively.
2.4. Baseline Models
In order to evaluate the effectiveness of the proposed model, we compare
its prediction performance with the performances of a set of baseline mod-
els. Specifically, we implemented Logistic Regression (LR)(Le Cessie and
Van Houwelingen, 1992), Random Forest (RF) (Breiman, 2001), and Gradi-
ent Boosting Decision Tree (GBDT) (Friedman, 2002) as the baseline models.
To construct the input vector of these models, for time-dependent continu-
ous variables (e.g., lab tests and chart-events) derived from structured EHR
data, we calculate the statistics within the observation window including the
first, last, average, minimum, maximum, slope and the count. For discrete
variables (e.g., medication and comorbidities) derived from structured EHR
data, we encode them as zero-one multi-hot vectors. Demographics data are
also considered. In particular, gender and ethnicity are seen as discrete vari-
ables and age is considered as continuous variable. In this way, the structured
EHR data within the observation window of each ICU stay is represented as a
147-dimension feature vector. For unstructured clinical notes, we construct a
bag-of-words vector from the collection of clinical notes in each ICU stay. For
the implementations of LR and RF, we use the Scikit-learn software library
(Pedregosa et al., 2011). For the GBDT, we use the XGBoost software li-
brary (Chen and Guestrin, 2016). In addition to these conventional machine
learning models, we also implement LSTM and two-layer hierarchical LSTM
for prediction based on pure structured and unstructured EHR information.
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Figure 2: An illustration of the proposed framework. An ICU stay representation v is de-
rived by integrating structured and unstructured EHR data. Time-dependent structured
EHR data (clinical sequences) is push into the memory by using embedding matrices A
and B. Unstructured EHR data (clinical notes) is represented as a vector u by using
hierarchical LSTM, which is combined with input memory vectors to retrieve important
information from output memory vectors to form a vector o. Static information is inte-
grated with o and u to form an ICU stay representative vector v.
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3. Results and Discussions
3.1. Patient Representation Learning
As introduced above, the first step of our pipeline is to learn an effec-
tive representation that can predict the risk of AKI. In experiment, we used
the nested cross-validation (Statnikov et al., 2004), which an outer 5-cross-
validation was used to split our dataset into training data and testing data,
and an inner 5-cross-validation on training data was used for tuning the pa-
rameters. Table 1 and Table 2 showed the performance (average ± standard
deviation) of our approach together with the baseline models introduced in
Section 2.4 in terms of AUC(Area Under the Receiver Operating Charac-
teristic Curve), precision, and recall (cutoff of 0.5). From these results, we
observe that:
• Compared to the performance from only unstructured data (i.e., clinical
notes), incorporating both structured and unstructured EHR data can
lead to an improved performance. One potential reason is that the
structured data contains information related to AKI such as lab tests
and chart events.
• The combination of unstructured data and structured data improved
the performance, which suggests that there is complementary infor-
mation contained in both structured and unstructured EHR that is
beneficial to the prediction. In particular, clinical notes on MIMIC-III
dataset mainly contain several types of notes: (1) echo reports; (2)
ECG reports; (3) radiology reports; (4) summary of hospital course of
a patient; (5) discharge summary; (6) diagnose descriptions; (7) pa-
tient past medical histories. These information can provide multiple
evidences and a comprehensive profile for patient current pathophysio-
logic conditions, for example, patient past medical histories (e.g., car-
diac surgery history) can provide implications for patient conditions.
The information from multiple kinds of reports may show some con-
nections with AKI.
• Deep learning models (e.g., LSTM and HieLSTM) obtained better re-
sults than traditional classification algorithms in all three cases. One
potential reason is that such models can capture the temporal depen-
dencies among the structured events and unstructured clinical notes,
which could be beneficial to the prediction of AKI risk.
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Table 1: The prediction performance of different methods based on structured and un-
structured EHR data produced during 24 hours after admission
Data Methods AUC Precision Recall
LR 0.6596±0.0061 0.2897±0.0122 0.5532±0.0128
Unstr RF 0.6645±0.0082 0.2941±0.013 0.5536±0.0135
GBDT 0.6797±0.0071 0.2978±0.0135 0.5603±0.0142
HieLSTM 0.6998±0.0113 0.2992±0.0142 0.5605±0.0149
LR 0.6823±0.0052 0.3115±0.0142 0.5834±0.0152
Str RF 0.6999±0.007 0.3136±0.0143 0.5836±0.0152
GBDT 0.7021±0.0071 0.3455±0.0151 0.5956±0.0154
LSTM 0.7099±0.0091 0.3604±0.016 0.5959±0.0162
LR 0.7199±0.0062 0.4112±0.0131 0.5997±0.014
Unstr RF 0.7201±0.0094 0.4222±0.0132 0.5998±0.0143
+Str GBDT 0.7319±0.0083 0.4336±0.0142 0.6009±0.0145
LSTM 0.7431±0.0095 0.4531±0.0149 0.6101±0.0152
MN+HieLSTM 0.7753±0.0126 0.4994±0.0155 0.6304±0.0161
• Our proposed methodology, which integrates both structured and un-
structured information through a deep learning model architecture,
yields the best performance.
Because the last layer before the output for our proposed model shown in
Figure 1 is a simple fully-connected logistic regression, its superior perfor-
mance really comes from the good patient representation vectors that serve
as the inputs to the logistic regressor.
In addition, in order to investigate the importance of using clinical notes,
we further examined important words by ranking “feature importances ” in
the GBDT over bag-of-words. The top 10 important words are “lasix”, “ci”,
“labile”, “insulin”, “wires”, “cabg”, “dilantin”, “neuro”, “jaundiced”, and
“cvp”. These words appear to be clinically meaningful. For example, the
word “lasix” is one kind of diuretic, which have a potential to provide treat-
ment for the retention that are caused by kidney dysfunction. The word
“cabg (Coronary artery bypass surgery)” provide an implication since these
patients have a potential to suffer from kidney injury post-operatively (Kertai
et al., 2016).
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Table 2: The prediction performance of different methods based on structured and un-
structured EHR data produced during 48 hours after admission
Data Methods AUC Precision Recall
LR 0.6603±0.0059 0.2901±0.0117 0.5568±0.0119
Unstr RF 0.6651±0.0074 0.2952±0.014 0.5598±0.0136
GBDT 0.6802±0.007 0.2983±0.0141 0.5692±0.0149
HieLSTM 0.7002±0.0116 0.3001±0.0144 0.5703±0.0151
LR 0.6899±0.0047 0.3126±0.0142 0.5935±0.0153
Str RF 0.7003±0.006 0.3145±0.0145 0.5991±0.0152
GBDT 0.7091±0.0069 0.3502±0.0151 0.5999±0.0155
LSTM 0.7133±0.0088 0.3664±0.0163 0.6002±0.0163
LR 0.7211±0.0058 0.4201±0.0142 0.6089±0.0148
Unstr RF 0.7293±0.0095 0.4289±0.0135 0.6112±0.0149
+Str GBDT 0.7345±0.0084 0.4397±0.0141 0.6119±0.0152
LSTM 0.7505±0.0093 0.4609±0.0152 0.6198±0.0159
MN+HieLSTM 0.7798±0.0131 0.5011±0.0162 0.6397±0.0177
3.2. Identifying AKI Sub-Phenotypes
We take EHR data produced during 24 hours after admission (i.e., pp
=24 in Figure 1) as an example to investigate the discovering of AKI sub-
phenotypes and perform statistical analysis in the following experiments.
In particular, after the patient representations were obtained, we first used
student t-distributed Stochastic Neighbor Embedding (t-SNE) (Maaten and
Hinton, 2008; Van Der Maaten et al., 2009) to embed the patient data into a
2-dimensional space, such that the information can be visually inspected for
identification of potential clusters. Then K-means clustering was performed
in the 2-dimensional space to computationally identify the clusters. In our
study, since the goal is to identify AKI sub-phenotypes, we perform clustering
on the representation vectors of all the 7,657 AKI cases.
The results of t-SNE embedding and clustering results are shown in Fig-
ure 3 and Figure 4. We consider PCA and auto-encoder methods as two
baselines to compare the clustering results. Compared with Figure 3 (a)(b)
and Figure 4 (a)(b), the three sub-phenotype depicted in Figure 3 (c) and
Figure 4 (c) are much more salient, with a better separation in scatterplot
(smaller intra-cluster distance and larger inter-cluster distance). The opti-
mal number of clusters, which is three in this case, is determined by the
Mcclain-Rao index (McClain and Rao, 1975). The identified patient clusters
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are represented with different colors in Figure 4. In the following subsec-
tion, we discuss the interpretation of these computationally derived AKI
sub-phenotypes.
(a) (b) (c)
Figure 3: The result of t-SNE: (a), (b), and (c) indicate the representation of patients is
obtained by PCA, auto-encoder, and our method, respectively.
(a) (b) (c)
Figure 4: The results of k-means clustering: (a), (b), and (c) indicate the representation
of patients is obtained by PCA, auto-encoder, and our method, respectively.
3.3. AKI Sub-Phenotype Interpretation
In order to interpret the three sub-phenotypes, we performed statistical
analyses on each of them to identify the patient features that are discrim-
inative among them. In particular, we performed Chi-square test (Lowry,
2014) and One-way ANOVA test (McDonald, 2009) for normally distributed
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features, and non-parametric testing (Kruskal and Wallis, 1952) for features
that are not normally distributed. Posthoc Tukey HSD test (Tukey et al.,
1949) was performed for multiplicity correction. Note that, the average of
multiple measurements in terms of continuous variables within first 24-hour of
admission are computed for statistical comparison between sub-phenotypes.
The results are shown in Table 3 and Table 4. From these tables, we can
see that the following features are significantly different across the three sub-
types: Glucose, Albumin, Diastolic Blood Pressure (DiasBP), Age, Lactate,
Creatinine, Hemoglobin, Partial Thromboplastin Time (PTT), White Blood
Count (WBC), Urine, and estimated Glomerular Filtration Rate (eGFR).
After Age adjustment, the following features are still significantly different:
• Glucose. Diabetes has been shown to be a big risk factor for kidney
disease and there are lots of studies on diabetic kidney disease (de Boer
et al., 2011; Seaquist et al., 1989; Tuttle et al., 2014). It has also
been shown that “AKI risk is most likely being increased in diabetic
individuals” (Patschan and Mu¨ller, 2016).
• Albumin. Albumin is a protein made by the liver. When the kidney
begins to fail, the albumin will leak to the urine and cause a low blood
albumin.
• Creatinine. Creatinine is a waste product from the normal breakdown
of muscle tissue, which is filtered through the kidneys and excreted in
urine. Creatinine level measures the kidney function.
• WBC. The white blood cells are cells fighting infections. A high WBC
level may indicate problems like infection or inflammation. As inflam-
matory response plays a key role in the development of AKI, there are
also studies on how WBC and AKI are related (e.g., (Han et al., 2014)).
• Urine. This is the 24-hour urine volume test, which measures the kidney
function.
• eGFR. This stands for the glomerular filtration rate estimated based
on the creatinine test. It also measures the kidney function.
Therefore, all these identified feature variables are highly correlated with
kidney function and AKI.
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Table 3: The results of statistical analyses on discrete variables (Number(Percentage),
aChi-square test)
Subtype I Subtype II Subtype III Unadjusted Adjusted
(N=4553) (N=672) (N=2432) P-value ANCOVA∗
Male 2928(64.31%) 310(46.13%) 1334(54.85%) 0.520a 0.512
Female 1625(35.69%) 362(53.87%) 1098(45.15%)
Ethnicity White 924(20.29%) 94(13.99%) 603(24.79%)
Ethnicity Black 2514(55.22%) 463(68.9%) 1315(54.07%) 0.567a 0.602
Ethnicity Asian 674(14.8%) 72(10.71%) 408(16.78%)
Ethnicity others 441(9.69%) 43(6.4%) 106(4.39%)
Diuretics 601(13.2%) 171(25.44%) 406(16.69%) 0.542a 0.432
Nsaid 555(12.19%) 167(24.85%) 399(16.41%) 0.482a 0.543
Angiotensin 641(14.08%) 174(25.89%) 418(17.19%) 0.540a 0.603
CHF 2739(60.16%) 441(65.63%) 1532(62.99%) 0.534a 0.624
PV: 677(14.87%) 115(17.11%) 455(18.71%) 0.591a 0.577
Hypertension 2759(60.6%) 405(60.27%) 1433(58.92%) 0.589a 0.612
Diabetes 1409(30.95%) 298(44.35%) 1081(44.45%) 0.457a 0.521
LD 602(13.22%) 103(15.33%) 341(14.02%) 0.591a 0.614
Mi 567(12.45%) 99(14.73%) 364(14.97%) 0.063a 0.145
Cad 1632(35.84%) 321(47.76%) 1210(49.75%) 0.465a 0.513
Cirrhosis 410(9.01%) 81(12.05%) 291(11.97%) 0.563a 0.633
Jaundice 201(4.41%) 46(6.85%) 149(6.13%) 0.313a 0.453
∗ANCOVA was performed to adjust significant in terms of age variable.
CHF: Congestive Heart Failure; PV: Peripheral Vascular; LD: Liver
Disease; CAD: Coronary Artery Disease; MI: Myocardial Infarction.
We further demonstrate the values of these features in different sub-
phenotypes in Figure 5. From the figure we can see that sub-phenotype
I is with mild kidney dysfunction and sub-phenotype II is with severe kidney
dysfunction, while sub-phenotype III is in between.
In order to further validate our observations, we checked the AKI severity
of those patients in different sub-phenotypes. We used the AKI staging
criteria from KDIGO as we introduced in Section 2.1. We found that sub-
phenotype I is mainly with stage I, sub-phenotype II is mainly associated
with stage III AKI, while sub-phenotype III is mainly associated with stage
II AKI. The compositions of the three sub-phenotypes with respect to the
AKI stages are summarized in Table 5.
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Figure 5: The illustration of heatmap in terms of significant continuous variables in each
subtypes.
Table 5: The statistical results for AKI stages and subtypes
Stage 1 Stage 2 Stage 3
Subtype I (N=4553) 3236(71.07%) 957(21.02%) 360(7.9%)
Subtype II (N=672) 75(11.16%) 171(25.45%) 426(63.39%)
Subtype III (N=2432) 386(15.87%) 1609(66.16%) 437(17.97%)
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4. Conclusions and Future Directions
In this paper we propose a data-driven approach for identification of AKI
sub-phenotypes. Our approach is composed of three steps. In the first step
we develop a memory network based architecture to predict the AKI risk
by integrating both the structured and unstructured information in patient
EHRs. In the second step we will perform clustering based on the patient
representations derived from the first step. In the third step we identify
important features that are significantly different across the different clusters
and use them to interpret the clusters. On the MIMIC III data set, we
identified three AKI sub-phenotypes, and they correlate well with the three
stages of AKI very well.
There are two main points in terms of the clinical significance of this
study. In particular, firstly, the experimental setting on the proposed model
is based on prediction for a patient whether or not suffering from AKI in the
next 7 days. The experimental results show that the proposed model has
the potential to obtain a better representation. One of the clinical implica-
tions of this study is that, for a new patient admitted in ICU, the proposed
model can make a prediction with high accuracy for the patient whether or
not suffering from AKI. Secondly, since the etiology of AKI is complex, it
might be not enough to discover all the subtypes using known rules and some
important factors. The proposed model used all raw data to obtain patient
representations and discover subtypes, which has the potential to provide
some important information assisting clinicians to understand the patient
conditions (e.g., the severity of AKI in the next 7 days) in time and take
appropriate actions.
For the interpretation step, multiple-testing adjustment was applied to
the p-value in our reported results. Note that, the clusters were trained
using structured and unstructured data. The variables in reported statistical
results are from structured data, which is a part of data used for training
clusters. The p-values of these variables may be not very rigorous hypothesis
testing.
In the future, our proposed approach can be improved from the following
aspects (1) The proposed method is completely data-driven. We can consider
how to combine AKI domain knowledge in the model building process. (2)
We can add components such as attention mechanism to enhance the model
interpretability. (3) We will consider more important variable categories
(e.g., interventions, transfusions, diagnostics)(Koyner et al., 2018; Tomasˇev
21
et al., 2019) and replicate the identified sub-phenotypes on more data sets.
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